Jundishapur Journal of Microbiology

Published by: Neoscriber Demo Publisher
Crossmark

Seven-Year Trend of Antimicrobial Resistance of Acinetobacter and Pseudomonas spp. Causing Bloodstream Infections: A Retrospective Study from Shiraz, Southern Iran

Amir Hossein Babaei ORCID 1 , 2 , Gholamreza Pouladfar ORCID 2 , * , Bahman Pourabbas ORCID 2 , Zahra Jafarpour ORCID 2 , Samin Ektesabi ORCID 1 and Pejman Abbasi ORCID 2
Authors Information
1 Shiraz University of Medical Sciences, Shiraz, Iran
2 Professor Alborzi Clinical Microbiology Research Center, Nemazee Teaching Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
Article information
  • Jundishapur Journal of Microbiology: April 30, 2019, 12 (4); e85819
  • Published Online: April 23, 2019
  • Article Type: Research Article
  • Received: October 27, 2018
  • Revised: April 6, 2019
  • Accepted: April 7, 2019
  • DOI: 10.5812/jjm.85819

To Cite: Babaei A H, Pouladfar G, Pourabbas B, Jafarpour Z, Ektesabi S , et al. Seven-Year Trend of Antimicrobial Resistance of Acinetobacter and Pseudomonas spp. Causing Bloodstream Infections: A Retrospective Study from Shiraz, Southern Iran, Jundishapur J Microbiol. 2019 ; 12(4):e85819. doi: 10.5812/jjm.85819.

Abstract
Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Biswas I. Genetic tools for manipulating Acinetobacter baumannii genome: An overview. J Med Microbiol. 2015;64(7):657-69. doi: 10.1099/jmm.0.000081. [PubMed: 25948809].
  • 2. Pourabbas B, Firouzi R, Pouladfar G. Characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex isolates from nosocomial bloodstream infections in southern Iran. J Med Microbiol. 2016;65(3):235-9. doi: 10.1099/jmm.0.000219. [PubMed: 26747061].
  • 3. Callejas-Diaz A, Fernandez-Perez C, Ramos-Martinez A, Munez-Rubio E, Sanchez-Romero I, Vargas Nunez JA. Impact of Pseudomonas aeruginosa bacteraemia in a tertiary hospital: Mortality and prognostic factors. Med Clin (Barc). 2019;152(3):83-9. doi: 10.1016/j.medcli.2018.04.020. [PubMed: 29885868].
  • 4. Shorr AF, Zilberberg MD, Micek ST, Kollef MH. Predictors of hospital mortality among septic ICU patients with Acinetobacter spp. bacteremia: A cohort study. BMC Infect Dis. 2014;14:572. doi: 10.1186/s12879-014-0572-6. [PubMed: 25358621]. [PubMed Central: PMC4216657].
  • 5. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):1198-208. doi: 10.1056/NEJMoa1306801. [PubMed: 24670166]. [PubMed Central: PMC4648343].
  • 6. Gandra S, Mojica N, Klein EY, Ashok A, Nerurkar V, Kumari M, et al. Trends in antibiotic resistance among major bacterial pathogens isolated from blood cultures tested at a large private laboratory network in India, 2008-2014. Int J Infect Dis. 2016;50:75-82. doi: 10.1016/j.ijid.2016.08.002. [PubMed: 27522002]. [PubMed Central: PMC5063511].
  • 7. Poorabbas B, Mardaneh J, Rezaei Z, Kalani M, Pouladfar G, Alami MH, et al. Nosocomial infections: Multicenter surveillance of antimicrobial resistance profile of Staphylococcus aureus and Gram negative rods isolated from blood and other sterile body fluids in Iran. Iran J Microbiol. 2015;7(3):127-35. [PubMed: 26668699]. [PubMed Central: PMC4676981].
  • 8. Moradi J, Hashemi FB, Bahador A. Antibiotic resistance of Acinetobacter baumannii in Iran: A systemic review of the published literature. Osong Public Health Res Perspect. 2015;6(2):79-86. doi: 10.1016/j.phrp.2014.12.006. [PubMed: 25938016]. [PubMed Central: PMC4411348].
  • 9. Rahbarimanesh A, Mojtahedi SY, Sadeghi P, Ghodsi M, Kianfar S, Khedmat L, et al. Antimicrobial stewardship program (ASP): An effective implementing technique for the therapy efficiency of meropenem and vancomycin antibiotics in Iranian pediatric patients. Ann Clin Microbiol Antimicrob. 2019;18(1):6. doi: 10.1186/s12941-019-0305-1. [PubMed: 30696456]. [PubMed Central: PMC6352345].
  • 10. Clinical and Laboratory Standards Institute (CLSI). M07-A10 - Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved standard. 10th ed. Wayne, PA, USA: CLSI; 2015.
  • 11. Galani I, Kontopidou F, Souli M, Rekatsina PD, Koratzanis E, Deliolanis J, et al. Colistin susceptibility testing by Etest and disk diffusion methods. Int J Antimicrob Agents. 2008;31(5):434-9. doi: 10.1016/j.ijantimicag.2008.01.011. [PubMed: 18328674].
  • 12. Japoni A, Kalani M, Farshad S, Ziyaeyan M, Alborzi A, Mehrabani D, et al. Antibiotic-resistant bacteria in hospitalized patients with bloodstream infections: Analysis of some associated factors. Iran Red Cres Med J. 2010;12(2):163-71.
  • 13. Japoni S, Farshad S, Abdi Ali A, Japoni A. Antibacterial susceptibility patterns and cross-resistance of acinetobacter, isolated from hospitalized patients, southern Iran. Iran Red Crescent Med J. 2011;13(11):832-6. [PubMed: 22737424]. [PubMed Central: PMC3371892].
  • 14. Asif M, Alvi IA, Rehman SU. Insight into Acinetobacter baumannii: Pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. Infect Drug Resist. 2018;11:1249-60. doi: 10.2147/IDR.S166750. [PubMed: 30174448]. [PubMed Central: PMC6110297].
  • 15. Lafaurie M, Porcher R, Donay JL, Touratier S, Molina JM. Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: A 10 year study. J Antimicrob Chemother. 2012;67(4):1010-5. doi: 10.1093/jac/dkr555. [PubMed: 22240401].
  • 16. Lewis GJ, Fang X, Gooch M, Cook PP. Decreased resistance of Pseudomonas aeruginosa with restriction of ciprofloxacin in a large teaching hospital's intensive care and intermediate care units. Infect Control Hosp Epidemiol. 2012;33(4):368-73. doi: 10.1086/664763. [PubMed: 22418632].
  • 17. Joseph NM, Devi S, Shashikala P, Kanungo R. Changing trend in the antibiotic resistance pattern of Pseudomonas aeruginosa isolated from wound swabs of out-patients and in-patients of a tertiary care hospital. J Clin Diagn Res. 2013;7(10):2170-2. doi: 10.7860/JCDR/2013/6113.3461. [PubMed: 24298467]. [PubMed Central: PMC3843476].
  • 18. Hu FP, Guo Y, Zhu DM, Wang F, Jiang XF, Xu YC, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014. Clin Microbiol Infect. 2016;22 Suppl 1:S9-14. doi: 10.1016/j.cmi.2016.01.001. [PubMed: 27000156].
  • 19. Juarez P, Jeannot K, Plesiat P, Llanes C. Toxic electrophiles induce expression of the multidrug efflux pump mexEF-OprN in Pseudomonas aeruginosa through a novel transcriptional regulator, CmrA. Antimicrob Agents Chemother. 2017;61(8). doi: 10.1128/AAC.00585-17. [PubMed: 28507116]. [PubMed Central: PMC5527617].
  • 20. Ponce-de-Leon A, Rodriguez-Noriega E, Morfin-Otero R, Cornejo-Juarez DP, Tinoco JC, Martinez-Gamboa A, et al. Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the study for monitoring antimicrobial resistance trends (SMART). PLoS One. 2018;13(6). e0198621. doi: 10.1371/journal.pone.0198621. [PubMed: 29927958]. [PubMed Central: PMC6013120].
  • 21. Amin Shahidi M, Anvarinejad M, Abbasian A, Abbasi P, Rafaatpour N, Dehyadegari MA, et al. [Characterization of multi-drug resistant ESBL producing nonfermenter bacteria isolated from patients blood samples using phenotypic methods in Shiraz (Iran)]. J Birjand Univ Med Sci. 2015;22(3):256-65. Persian.
  • 22. Niu T, Xiao T, Guo L, Yu W, Chen Y, Zheng B, et al. Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem-resistant Acinetobacter baumannii bloodstream infections: cefoperazone-sulbactam associated with resistance and tigecycline increased the mortality. Infect Drug Resist. 2018;11:2021-30. doi: 10.2147/IDR.S169432. [PubMed: 30464544]. [PubMed Central: PMC6208797].
  • 23. De Silva PM, Kumar A. Signal transduction proteins in Acinetobacter baumannii: Role in antibiotic resistance, virulence, and potential as drug targets. Front Microbiol. 2019;10:49. doi: 10.3389/fmicb.2019.00049. [PubMed: 30761101]. [PubMed Central: PMC6363711].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments